Study of ADXS11-001 in Participants With High Risk Locally Advanced Cervical Cancer

NCT02853604 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

High Risk Cervical Cancer
Advanced Cervical Cancer

Interventions

DRUG: ADXS11-001
DRUG: Placebo

Sponsor

Advaxis, Inc.

Collaborators

[object Object]